Pharmena Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 7

Employees

  • Stock Symbol
  • PHR

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.67
  • (As of Thursday Closing)

Pharmena General Information

Description

Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.

Contact Information

Website
www.pharmena.eu
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Ul. Wólczanska 178
  • Lodz, 90-729
  • Poland
+48 728
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Stock Exchange
WAR
Corporate Office
  • Ul. Wólczanska 178
  • Lodz, 90-729
  • Poland
+48 728

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmena Stock Performance

As of 19-Nov-2026, Pharmena’s stock price is $0.67. Its current market cap is $7.5M with 11.1M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.67 $0.68 $0.65 - $1.20 $7.5M 11.1M 2.74K -$0.07

Pharmena Financials Summary

As of 30-Jun-2026, Pharmena has a trailing 12-month revenue of $401K.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 7,620 5,749 7,810 14,501
Revenue 401 419 67 298
EBITDA (879) (838) (829) (2,835)
Net Income (839) (736) (317) (3,775)
Total Assets 2,540 3,034 3,289 6,252
Total Debt 84 102 59 45
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pharmena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmena‘s full profile, request access.

Request a free trial

Pharmena Patents

Pharmena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021205341-A1 1-methylnicotinamide for the prevention/treatment of inflammatory airway diseases Inactive 07-Apr-2020
ES-2967074-T3 1 methylnicotinamide for the treatment of cardiovascular disease Active 18-Jul-2016
JP-2019521160-A 1-methylnicotinamide for the treatment of c-reactive protein related diseases Pending 18-Jul-2016
EP-3484475-B1 1-methylnicotinamide for the treatment of cardiovascular disease Active 18-Jul-2016
AU-2017298648-A1 1-methylnicotinamide for the treatment of diseases associated with c-reactive protein Active 18-Jul-2016 A61K31/455
To view Pharmena’s complete patent history, request access »

Pharmena Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmena Acquisitions (1)

Pharmena’s most recent deal was a Merger/Acquisition with Cortria. The deal was made on 20-Aug-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cortria 20-Aug-2010 Merger/Acquisition Pharmaceuticals
To view Pharmena’s complete acquisitions history, request access »

Pharmena ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Household Products

Industry

Rank

Percentile

Personal Products

Subindustry

Rank

Percentile

To view Pharmena’s complete esg history, request access »

Pharmena FAQs

  • When was Pharmena founded?

    Pharmena was founded in 2002.

  • Where is Pharmena headquartered?

    Pharmena is headquartered in Lodz, Poland.

  • What is the size of Pharmena?

    Pharmena has 7 total employees.

  • What industry is Pharmena in?

    Pharmena’s primary industry is Personal Products.

  • Is Pharmena a private or public company?

    Pharmena is a Public company.

  • What is Pharmena’s stock symbol?

    The ticker symbol for Pharmena is PHR.

  • What is the current stock price of Pharmena?

    As of 19-Nov-2026 the stock price of Pharmena is $0.67.

  • What is the current market cap of Pharmena?

    The current market capitalization of Pharmena is $7.5M.

  • What is Pharmena’s current revenue?

    The trailing twelve month revenue for Pharmena is $401K.

  • What is Pharmena’s annual earnings per share (EPS)?

    Pharmena’s EPS for 12 months was -$0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process